Skip to main content
Top
Published in: Journal of Neurology 6/2017

01-06-2017 | Letter to the Editors

Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report

Authors: E. M. Rodenburg, F. H. Vermeij, M. J. van den Bent, J. M. Zuetenhorst

Published in: Journal of Neurology | Issue 6/2017

Login to get access

Excerpt

Dear Sirs, …
Literature
1.
go back to reference Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130(11):922–932CrossRefPubMed Cohen JI, Brunell PA, Straus SE, Krause PR (1999) Recent advances in varicella-zoster virus infection. Ann Intern Med 130(11):922–932CrossRefPubMed
2.
go back to reference Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD (1992) Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166(5):1153–1156CrossRefPubMed Buchbinder SP, Katz MH, Hessol NA, Liu JY, O’Malley PM, Underwood R, Holmberg SD (1992) Herpes zoster and human immunodeficiency virus infection. J Infect Dis 166(5):1153–1156CrossRefPubMed
3.
go back to reference Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537–544CrossRefPubMedPubMedCentral Hata A, Kuniyoshi M, Ohkusa Y (2011) Risk of Herpes zoster in patients with underlying diseases: a retrospective hospital-based cohort study. Infection 39(6):537–544CrossRefPubMedPubMedCentral
4.
go back to reference Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645CrossRefPubMed Gilden DH, Kleinschmidt-DeMasters BK, LaGuardia JJ, Mahalingam R, Cohrs RJ (2000) Neurologic complications of the reactivation of varicella-zoster virus. N Engl J Med 342(9):635–645CrossRefPubMed
5.
go back to reference Rusthoven JJ, Ahlgren P, Elhakim T, Pinfold P, Reid J, Stewart L, Feld R (1988) Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 148(7):1561–1566CrossRefPubMed Rusthoven JJ, Ahlgren P, Elhakim T, Pinfold P, Reid J, Stewart L, Feld R (1988) Varicella-zoster infection in adult cancer patients. A population study. Arch Intern Med 148(7):1561–1566CrossRefPubMed
6.
go back to reference Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL et al (2012) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomark Prev 22(1):82–90CrossRef Habel LA, Ray GT, Silverberg MJ, Horberg MA, Yawn BP, Castillo AL et al (2012) The epidemiology of herpes zoster in patients with newly diagnosed cancer. Cancer Epidemiol Biomark Prev 22(1):82–90CrossRef
7.
go back to reference Calabria F, Zappini F, Vattemi G, Tinazzi M (2014) Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy. Neurology 82(2):e14–e15CrossRefPubMed Calabria F, Zappini F, Vattemi G, Tinazzi M (2014) Pearls & Oy-sters: an unusual case of varicella-zoster virus cerebellitis and vasculopathy. Neurology 82(2):e14–e15CrossRefPubMed
8.
go back to reference Mpaka M, Karantanas AH, Zakynthinos E (2008) Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 37(1):61–66CrossRefPubMed Mpaka M, Karantanas AH, Zakynthinos E (2008) Atypical presentation of varicella-zoster virus encephalitis in an immunocompetent adult. Heart Lung 37(1):61–66CrossRefPubMed
9.
go back to reference De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP (2011) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18(8):808–819CrossRefPubMed De Broucker T, Mailles A, Chabrier S, Morand P, Stahl JP (2011) Acute varicella zoster encephalitis without evidence of primary vasculopathy in a case-series of 20 patients. Clin Microbiol Infect 18(8):808–819CrossRefPubMed
10.
go back to reference Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2013) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93(3):479–484CrossRefPubMed Konig C, Kleber M, Reinhardt H, Knop S, Wasch R, Engelhardt M (2013) Incidence, risk factors, and implemented prophylaxis of varicella zoster virus infection, including complicated varicella zoster virus and herpes simplex virus infections, in lenalidomide-treated multiple myeloma patients. Ann Hematol 93(3):479–484CrossRefPubMed
11.
go back to reference Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33(10):786–788CrossRefPubMed Tattevin P, Schortgen F, de Broucker T, Dautheville S, Wolff M (2001) Varicella-zoster virus limbic encephalitis in an immunocompromised patient. Scand J Infect Dis 33(10):786–788CrossRefPubMed
12.
go back to reference Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17(7):e529–e534CrossRefPubMed Becerra JC, Sieber R, Martinetti G, Costa ST, Meylan P, Bernasconi E (2013) Infection of the central nervous system caused by varicella zoster virus reactivation: a retrospective case series study. Int J Infect Dis 17(7):e529–e534CrossRefPubMed
13.
go back to reference Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A (2006) Herpes infections in breast cancer patients treated with adjuvant chemotherapy. Oncology 71(3–4):164–167PubMed Masci G, Magagnoli M, Gullo G, Morenghi E, Garassino I, Simonelli M, Santoro A (2006) Herpes infections in breast cancer patients treated with adjuvant chemotherapy. Oncology 71(3–4):164–167PubMed
14.
go back to reference König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(3):944–966CrossRefPubMed König J, Müller F, Fromm MF (2013) Transporters and drug–drug interactions: important determinants of drug disposition and effects. Pharmacol Rev 65(3):944–966CrossRefPubMed
15.
go back to reference Lee CA, O’Connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-Majlessi I et al (2015) Breast Cancer Resistance Protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug–drug interaction study design. Drug Metab Dispos 43:490–509CrossRefPubMed Lee CA, O’Connor MA, Ritchie TK, Galetin A, Cook JA, Ragueneau-Majlessi I et al (2015) Breast Cancer Resistance Protein (ABCG2) in clinical pharmacokinetics and drug interactions: practical recommendations for clinical victim and perpetrator drug–drug interaction study design. Drug Metab Dispos 43:490–509CrossRefPubMed
Metadata
Title
Varicella zoster virus encephalitis in a patient with a solid carcinoma: a case report
Authors
E. M. Rodenburg
F. H. Vermeij
M. J. van den Bent
J. M. Zuetenhorst
Publication date
01-06-2017
Publisher
Springer Berlin Heidelberg
Published in
Journal of Neurology / Issue 6/2017
Print ISSN: 0340-5354
Electronic ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8466-3

Other articles of this Issue 6/2017

Journal of Neurology 6/2017 Go to the issue

Neurological Update

Neuroborreliosis